Most human infectious diseases are caused by microorganisms growing as biofilms. These three-dimensional self-organized communities are embedded in a dense matrix allowing microorganisms to persistently inhabit abiotic and biotic surfaces due to increased resistance to both antibiotics and effectors of the immune system. Consequently, there is an urgent need for novel strategies to control biofilm-associated infections. Natural products offer a vast array of chemical structures and possess a wide variety of biological properties; therefore, they have been and continue to be exploited in the search for potential biofilm inhibitors with a specific or multi-locus mechanism of action. This review provides an updated discussion of the major bioactive compounds isolated from several natural sources - such as plants, lichens, algae, microorganisms, animals, and humans - with the potential to inhibit biofilm formation and/or to disperse established biofilms by bacterial pathogens. Despite the very large number of bioactive products, their exact mechanism of action often remains to be clarified and, in some cases, the identity of the active molecule is still unknown. This knowledge gap should be filled thus allowing development of these products not only as novel drugs to combat bacterial biofilms, but also as antibiotic adjuvants to restore the therapeutic efficacy of current antibiotics.

Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? / Pompilio, Arianna; Scocchi, Marco; Mangoni, Maria Luisa; Shirooie, Samira; Serio, Annalisa; Ferreira Garcia da Costa, Ygor; Alves, Maria Silvana; Şeker Karatoprak, Gökçe; Süntar, Ipek; Khan, Haroon; Di Bonaventura, Giovanni. - In: CRITICAL REVIEWS IN MICROBIOLOGY. - ISSN 1040-841X. - (2022), pp. 1-33-33. [10.1080/1040841X.2022.2038082]

Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms?

Mangoni, Maria Luisa;
2022

Abstract

Most human infectious diseases are caused by microorganisms growing as biofilms. These three-dimensional self-organized communities are embedded in a dense matrix allowing microorganisms to persistently inhabit abiotic and biotic surfaces due to increased resistance to both antibiotics and effectors of the immune system. Consequently, there is an urgent need for novel strategies to control biofilm-associated infections. Natural products offer a vast array of chemical structures and possess a wide variety of biological properties; therefore, they have been and continue to be exploited in the search for potential biofilm inhibitors with a specific or multi-locus mechanism of action. This review provides an updated discussion of the major bioactive compounds isolated from several natural sources - such as plants, lichens, algae, microorganisms, animals, and humans - with the potential to inhibit biofilm formation and/or to disperse established biofilms by bacterial pathogens. Despite the very large number of bioactive products, their exact mechanism of action often remains to be clarified and, in some cases, the identity of the active molecule is still unknown. This knowledge gap should be filled thus allowing development of these products not only as novel drugs to combat bacterial biofilms, but also as antibiotic adjuvants to restore the therapeutic efficacy of current antibiotics.
2022
Bioactive natural compounds; antibiotic-resistance; bacterial biofilms; biofilm-associated infections; secondary metabolites
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Bioactive compounds: a goldmine for defining new strategies against pathogenic bacterial biofilms? / Pompilio, Arianna; Scocchi, Marco; Mangoni, Maria Luisa; Shirooie, Samira; Serio, Annalisa; Ferreira Garcia da Costa, Ygor; Alves, Maria Silvana; Şeker Karatoprak, Gökçe; Süntar, Ipek; Khan, Haroon; Di Bonaventura, Giovanni. - In: CRITICAL REVIEWS IN MICROBIOLOGY. - ISSN 1040-841X. - (2022), pp. 1-33-33. [10.1080/1040841X.2022.2038082]
File allegati a questo prodotto
File Dimensione Formato  
Pompilio_Bioactive_2022.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 4.46 MB
Formato Adobe PDF
4.46 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1623738
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 12
social impact